Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells
- 22 June 2005
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 240 (1-2) , 23-31
- https://doi.org/10.1016/j.mce.2005.03.018
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunocytochemical restaining method.Pathology International, 2003
- American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast CancerJournal of Clinical Oncology, 2003
- Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survivalBritish Journal of Cancer, 2003
- The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxelBritish Journal of Cancer, 2001
- Bisphosphonates Induce Breast Cancer Cell Death In VitroJournal of Bone and Mineral Research, 2000
- Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral EnvironmentJournal of Bone and Mineral Research, 1999
- Telomerase Activity in Human Thyroid Carcinomas Originating from the Follicular CellsJournal of Clinical Endocrinology & Metabolism, 1997
- Clodronate and Liposome-Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′-(β,γ-Dichloromethylene) Triphosphate, by Mammalian Cells In VitroJournal of Bone and Mineral Research, 1997
- Telomerase Activity in Benign and Malignant Thyroid TumorsThyroid®, 1997
- Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone MetastasesNew England Journal of Medicine, 1996